114 related articles for article (PubMed ID: 1770066)
1. Effect of urokinase on preservation of renal function in patients with diabetic nephropathy.
Sakai H; Watanabe S; Inoue I; Tanaka K; Yagame M; Machimura H; Kaneshige H; Nomoto Y
J Diabet Complications; 1991; 5(2-3):95-7. PubMed ID: 1770066
[TBL] [Abstract][Full Text] [Related]
2. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
[TBL] [Abstract][Full Text] [Related]
3. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Hopper AH; Tindall H; Davies JA
Nephrol Dial Transplant; 1989; 4(2):140-3. PubMed ID: 2496357
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.
Inage H; Koyama A; Narita M; Tojo S
Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1261-70. PubMed ID: 4087547
[No Abstract] [Full Text] [Related]
5. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
Diabetes Care; 2000 Aug; 23(8):1168-71. PubMed ID: 10937516
[TBL] [Abstract][Full Text] [Related]
6. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
Khajehdehi P; Roozbeh J; Mostafavi H
Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
[TBL] [Abstract][Full Text] [Related]
7. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
Yamagishi S; Koga K; Inagaki Y; Amano S; Okamoto T; Takeuchi M
Drugs Exp Clin Res; 2002; 28(6):221-7. PubMed ID: 12776575
[TBL] [Abstract][Full Text] [Related]
8. Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study.
Koide H; Totsuka Y; Sugisaki T; Kitajima T; Ohmori Y; Kuriyama S; Oi K; Isogai S; Ohi H; Tomino Y
Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):644-8. PubMed ID: 8583701
[TBL] [Abstract][Full Text] [Related]
9. Effect of pancreatic elastase on diabetic nephropathy.
Nagai T; Tomizawa T; Mori M
Diabetes Care; 1993 Aug; 16(8):1214-5. PubMed ID: 8375257
[No Abstract] [Full Text] [Related]
10. Ameliorating effects of conventional therapy on declining renal function in patients with diabetic nephropathy.
Machimura H
Tokai J Exp Clin Med; 1991 Oct; 16(3-4):187-92. PubMed ID: 1811352
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
[TBL] [Abstract][Full Text] [Related]
12. The effect of dilazep on urinary protein excretion in spontaneous diabetic Chinese hamster.
Morikawa A; Eto M; Makino I
Nephron; 1993; 65(1):125-32. PubMed ID: 8413770
[TBL] [Abstract][Full Text] [Related]
13. Effect of dipyridamole on proteinuria of diabetic nephropathy.
Makino H; Okada S; Ota Z
Clin Nephrol; 1983 Sep; 20(3):160. PubMed ID: 6627765
[No Abstract] [Full Text] [Related]
14. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
[TBL] [Abstract][Full Text] [Related]
15. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy.
Pistrosch F; Passauer J; Herbrig K; Schwanebeck U; Gross P; Bornstein SR
Horm Metab Res; 2012 Nov; 44(12):914-8. PubMed ID: 22723267
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
17. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.
Lin YL; Peng SJ; Ferng SH; Tzen CY; Yang CS
Int J Clin Pract; 2009 Aug; 63(8):1167-76. PubMed ID: 18422591
[TBL] [Abstract][Full Text] [Related]
18. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function.
Baba T; Murabayashi S; Tomiyama T; Takebe K
Tohoku J Exp Med; 1990 Aug; 161(4):311-8. PubMed ID: 2256104
[TBL] [Abstract][Full Text] [Related]
19. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.
Khajehdehi P; Pakfetrat M; Javidnia K; Azad F; Malekmakan L; Nasab MH; Dehghanzadeh G
Scand J Urol Nephrol; 2011 Nov; 45(5):365-70. PubMed ID: 21627399
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of antiplatelet therapy for IgA nephropathy.
Taji Y; Kuwahara T; Shikata S; Morimoto T
Clin Exp Nephrol; 2006 Dec; 10(4):268-73. PubMed ID: 17186331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
